Ameriprise Financial Inc. cut its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 4.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,594,364 shares of the financial services provider's stock after selling 197,277 shares during the quarter. Ameriprise Financial Inc. owned 1.27% of CME Group worth $1,067,162,000 at the end of the most recent quarter.
A number of other hedge funds have also recently made changes to their positions in the business. Anchor Investment Management LLC grew its stake in shares of CME Group by 52.4% during the third quarter. Anchor Investment Management LLC now owns 378 shares of the financial services provider's stock valued at $83,000 after buying an additional 130 shares during the last quarter. Franklin Resources Inc. boosted its holdings in CME Group by 70.4% during the 3rd quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider's stock valued at $544,157,000 after acquiring an additional 1,003,119 shares during the period. Principal Financial Group Inc. grew its position in CME Group by 4.4% during the 3rd quarter. Principal Financial Group Inc. now owns 419,532 shares of the financial services provider's stock worth $92,570,000 after acquiring an additional 17,508 shares during the last quarter. GAMMA Investing LLC grew its position in CME Group by 36.2% during the 4th quarter. GAMMA Investing LLC now owns 5,626 shares of the financial services provider's stock worth $1,307,000 after acquiring an additional 1,495 shares during the last quarter. Finally, Nordea Investment Management AB lifted its position in CME Group by 5.4% in the fourth quarter. Nordea Investment Management AB now owns 30,170 shares of the financial services provider's stock valued at $7,000,000 after purchasing an additional 1,557 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.
CME Group Stock Up 0.7 %
NASDAQ CME traded up $1.86 on Friday, hitting $283.85. The stock had a trading volume of 402,950 shares, compared to its average volume of 2,151,120. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The stock has a market cap of $102.29 billion, a price-to-earnings ratio of 29.35, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $286.48. The business's fifty day moving average price is $263.82 and its 200 day moving average price is $245.14.
CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. The business had revenue of $1.64 billion during the quarter, compared to analysts' expectations of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The business's quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the company posted $2.50 earnings per share. Equities research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.
CME Group Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.76%. CME Group's dividend payout ratio is currently 50.30%.
Analyst Ratings Changes
A number of analysts have recently weighed in on the stock. UBS Group increased their target price on shares of CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a report on Friday, April 25th. Bank of America lifted their price objective on CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research report on Wednesday, April 2nd. Morgan Stanley lifted their price target on shares of CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a report on Thursday, April 24th. Raymond James raised shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 target price for the company in a research report on Monday, March 10th. Finally, Erste Group Bank upgraded shares of CME Group to a "strong-buy" rating in a research report on Monday, March 17th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, CME Group currently has a consensus rating of "Hold" and an average target price of $256.80.
Check Out Our Latest Report on CME Group
Insider Buying and Selling at CME Group
In other CME Group news, insider Hilda Harris Piell sold 3,984 shares of CME Group stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total transaction of $997,872.48. Following the sale, the insider now owns 27,046 shares of the company's stock, valued at $6,774,211.62. The trade was a 12.84 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Julie Winkler sold 11,592 shares of the stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the sale, the insider now owns 21,885 shares of the company's stock, valued at approximately $5,453,085.45. The trade was a 34.63 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 34,726 shares of company stock worth $8,975,813. Insiders own 0.30% of the company's stock.
CME Group Company Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report